Execution of manufacturing contract for manufacture, supply, quality assurance and packaging of nutraceutical and food products. The deal is expected to generate business revenues of INR ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 2.4 pts more than its Packaged Foods peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sampre Nutritions Ltd has entered into a manufacturing agreement with Rama Exports, Mumbai, dated 19 August 2025. Under the deal, Sampre will manufacture, supply, quality-check, and package nutraceutical and food products under its own brand names and specifications. Rama Exports will purchase the finished goods at mutually agreed prices over a 3-year term. The total business expected from this contract is around INR 15 crores over the contract period. The counterparty is not related to Sampre's promoters or group firms and holds no shares in the company.
Adds a contracted revenue stream of roughly INR 5 crores per year over the next 3 years, which should support top-line growth in Sampre's nutraceutical business. However, since the value is spread over 3 years, the annual impact is modest and depends on actual order execution.